Holen Sie sich die Stockscreener-App
48.02
0.04%
0.02
Handel nachbörslich:
48.02
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare Inc. (PBH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Trading Systems Reacting to (PBH) Volatility - Stock Traders Daily
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 39% Upside Potential Amidst Strong Analyst Ratings - DirectorsTalk Interviews
Why Is Prestige Consumer Healthcare Stock Trending - Kalkine Media
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages Prestige Consumer Healthcare Inc. (PBH) Investors to Inquire about Securities Investigation - ACCESS Newswire
Kinetics Spin-Off and Corporate Restructuring Fund's Prestige Consumer Healthcare Inc(PBH) Holding History - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Prestige Consumer H - The National Law Review
Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud InvestigationLevi & Korsinsky - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc.PBH - PR Newswire
Levi & Korsinsky Announces Investigation of Securities Claims Against Prestige Consumer Healthcare (PBH) - GlobeNewswire
Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call Transcript Summary - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare (PBH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
PBH Investor Alert: Levi & Korsinsky Investigates Prestige Consumer Healthcare (PBH) for Potential Securities Fraud - marketscreener.com
INVESTOR ALERT: Investigation of Prestige Consumer Healthcare Inc. (PBH) announced by Holzer & Holzer, LLC - GlobeNewswire
Prestige Consumer Healthcare (PBH) Valuation After Missed Q4 Targets And Delayed LaCorium Deal Disclosure - Sahm
PBH SHAREHOLDER INVESTIGATION: SueWallSt Investigates Prestige Consumer Healthcare for Possible Securities Law Violations - PR Newswire
Prestige Consumer Healthcare (PBH): Investor Outlook Reveals 48.88% Potential Upside - DirectorsTalk Interviews
Prestige Consumer Healthcare Q4 earnings call highlights - MSN
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Prestige Consumer Healthcare Inc. Just Missed EPS By 8.9%: Here's What Analysts Think Will Happen Next - 富途牛牛
Prestige Consumer Healthcare: Better Valuation, But Too Much Uncertainty To Buy - Seeking Alpha
Bessemer Group Inc. Acquires 32,331 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
How InvestingPro’s Fair Value spotted Prestige Healthcare’s 46% drop By Investing.com - Investing.com
Prestige Consumer Healthcare (PBH) Is Down 11.0% After Earnings Miss And Surprise LaCorium Deal DisclosureWhat's Changed - Sahm
PBH Maintains Buy Rating, Price Target Lowered to $72 by Canacco - GuruFocus
Prestige Consumer Healthcare Balances Setbacks With Growth Plan - The Globe and Mail
Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
Prestige Consumer Healthcare, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Prestige Consumer Healthcare (PBH) - Morningstar
Investigation launched over Prestige Consumer Healthcare's missed financial targets and undisclosed acquisition. - Pluang
Prestige Consumer Healthcare Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2026 Earnings Call Transcript - Insider Monkey
Prestige Consumer Healthcare Hits Day Low of $42.66 Amid Price Pressure - Markets Mojo
Prestige Consumer Healthcare Hits New 52-Week Low at $42.66 - Markets Mojo
Prestige Brands stock price target cut to $72 by Canaccord on sales miss - Investing.com Australia
Prestige Consumer Healthcare Inc. $PBH Shares Purchased by Leeward Investments LLC MA - MarketBeat
Oppenheimer downgrades Prestige Consumer Healthcare (PBH) - MSN
Prestige Consumer Healthcare Q4 Earnings Call Highlights - sharewise.com
Prestige Consumer Healthcare Inc. Overview: Major Brands, Competitive Strengths, and Growth Strategy in OTC Health Products - Minichart
PBH News | PRESTIGE CONSUMER HEALTHCARE (NYSE:PBH) - ChartMill
Prestige Consumer Healthcare Inc (PBH) Q4 2026 Earnings Call Hig - GuruFocus
Prestige Consumer Shares Slide on Weak Outlook, 4Q Underperformance - Moomoo
Prestige Consumer (PBH) Experiences Significant Decline - GuruFocus
How Prestige Consumer Healthcare Inc. (PBH) Affects Rotational Strategy Timing - Stock Traders Daily
Prestige Consumer Healthcare Inc (PBH) Shares Fall 11.3% -- What GF Score of 67 Tells Investors - GuruFocus
Prestige Consumer Healthcare forecasts $1.1B-$1.12B fiscal 2027 revenue with Clear Eyes growth weighted to the back half - MSN
Prestige Consumer (PBH) Downgraded by Oppenheimer Following Disa - GuruFocus
Prestige Consumer Hlthcr 4Q EPS $1.13 >PBH - Moomoo
Prestige Consumer Healthcare Inc. FY 2026: Revenue $1.09B, EPS $3.91— 10-K Summary - TradingView
OTC brand leader Prestige Consumer (PBH) outlines growth strategy and risks - Stock Titan
Prestige Consumer (PBH) CFO logs tax-related share withholding adjustment - Stock Titan
Prestige Consumer Healthcare Fiscal Q4 Adjusted Earnings, Revenue Fall; Issues Fiscal 2027 Guidance - Moomoo
Step Back in Clear Eyes Recovery and Macro Challenges Weigh on Prestige in Near Term - Morningstar
Prestige Consumer Healthcare Attributes Soft Results to Low Eye Care Sales, Weak Consumer Backdrop - marketscreener.com
PBH Q4 Earnings & Revenues Miss Estimates, Margins Down - Eastern Progress
Prestige Consumer Hlthcr Sees FY27 Free Cash Flow $250 M or More >PBH - Moomoo
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition Of LaCorium Health >PBH - Moomoo
Earnings call transcript: Prestige Consumer Healthcare Q4 2026 earnings miss impacts stock By Investing.com - Investing.com South Africa
Prestige Consumer Faces Execution Pressure After Weak Q4, Softer 2026 Outlook, Oppenheimer Says - marketscreener.com
Prestige Consumer Healthcare Down Over 13%, On Track for Largest Percent Decrease Since May 2012 -- Data Talk - Moomoo
Earnings call transcript: Prestige Consumer Healthcare Q4 2026 earnings miss impacts stock - Investing.com
Prestige Consumer Healthcare Inc. 2026 Q4ResultsEarnings Call Presentation (NYSE:PBH) 2026-05-14 - Seeking Alpha
Why is Prestige Consumer Healthcare stock tumbling today? By Investing.com - Investing.com Canada
5.02%
5.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):